天然产物研究与开发 ›› 2022, Vol. 34 ›› Issue (5): 874-886.doi: 10.16333/j.1001-6880.2022.5.017

• 数据研究 • 上一篇    下一篇

基于“免疫-炎症”环节探究小柴胡汤“异病同治”系统性红斑狼疮和肾小球肾炎的作用机制

常梦丽,郭非非,唐仕欢*,杨洪军   

  1. 中国中医科学院中药研究所,北京 100700
  • 出版日期:2022-05-28 发布日期:2022-05-23
  • 基金资助:
    山东省重点研发计划(2017CXGC1301);国家重点研发计划(2018YFC1704101);国家重大新药创制专项(2019ZX09201005, 2019ZX09721001-005-002)

Study on mechanisms of Xiaochaihu Decoction in treating systemic lupus erythematosus and glomerulonephritis with same-link method based on “immune-inflammation”

CHANG Meng-li,GUO Fei-fei,TANG Shi-huan*,YANG Hong-jun   

  1. Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China
  • Online:2022-05-28 Published:2022-05-23

摘要:

以自身免疫性疾病系统性红斑狼疮(systemic lupus erythematosus,SLE)和肾小球肾炎(glomerulonephritis,GN)为例,从“免疫-炎症”角度分析小柴胡汤“异病同治”的机理。基于GEO公共数据库搜索疾病样本数据并获得差异基因,利用String平台获得蛋白互作网络,基于Cytoscape 3.8.0筛选获得核心靶点,将核心靶点数据上传至中药药效预测平台构建疾病网络。基于中药药效预测平台并利用z-Score模型,对比临床治疗SLE与GN的上市西药与小柴胡汤对疾病网络的扰动情况。利用Cytoscape 3.8.0的ClueGo插件对小柴胡汤干预SLE、GN以及小柴胡汤干预二者的交集靶点进行GO分析和KEGG分析。结果得到SLE疾病95个核心差异基因和GN疾病112个核心差异基因,通过中药药效预测平台的分析得到小柴胡汤干预SLE的潜在靶点82个,小柴胡汤干预GN的潜在靶点77个,二者的交集靶点38个。GO分析和KEGG分析结果显示,小柴胡汤异病同治的机理可能是通过参与I型干扰素信号通路、病毒过程的负调控、对γ-干扰素的应答、B细胞增殖调节等免疫炎症相关的生物过程介导胞质DNA感应通路、NOD样受体信号通路、丙型肝炎等信号通路来实现。综上,小柴胡汤可通过参与免疫和炎症相关的通路治疗SLE与GN,可为小柴胡汤干预SLE和GN的进一步研究提供参考,有助于准确定位小柴胡汤异病同治的干预环节,为其精准应用提供依据。

关键词: 小柴胡汤, 红斑狼疮, 肾小球肾炎, 异病同治, 中药药效预测平台

Abstract:

This paper takes autoimmune disease such as systemic lupus erythematosus and glomerulonephritis as an example,for the purpose of analyzing the mechanism of Xiaochaihu Decoction treating different diseases with same method from an “immune-inflammation” point of view.The differential genes about SLE and GN were obtained from GEO database,then the protein-protein interaction network map was constructed by String database and the core targets were obtained based on Cytoscape 3.8.0,then the core target data were uploaded to the traditional Chinese medicine (TCM) efficacy prediction platform for the purpose of constructing the disease network.The disturbance scores of disease network of marketed western medicine for clinical treatment of SLE and GN and Xiaochaihu Decoction was compared based on the TCM efficacy prediction platform and z-Score model.GO analysis and KEGG analysis were performed on the targets of Xiaochaihu Decoction treating SLE,GN,and targets which is shared between them by using the ClueGo in Cytoscape 3.8.0.The 95 core targets about SLE and 112 core targets about GN,82 targets of Xiaochaihu Decoction treating SLE,77 targets of Xiaochaihu Decoction treating GN and 38 core targets which is shared between Xiaochaihu Decoction treating SLE and GN were obtained according to the above conditions.According the GO and KEGG analysis,the mechanism of Xiaochaihu Decoction treating different diseases with same method may be achieved by participating in type I interferon signaling pathway,negative regulation of viral processes,response to interferon-gamma,regulation of B cell proliferation and other immune inflammation-related biological processes and mediating cytosolic DNA sensing pathway,NOD-like receptor signaling pathway,hepatitis C and other signaling pathways.It is concluded that Xiaochaihu Decoction can treat SLE and GN through pathways related to immune process and inflammatory response,a reference for further study of Xiaochaihu Decoction treating SLE and GN is provided from this article,and can be helpful in accurately locate the disease process of Xiaochaihu Decoction treating different diseases with same method.

Key words: Xiaochaihu Decoction, systemic lupus erythematosus, glomerulonephritis, treating different diseases with same method, traditional Chinese medicine efficacy prediction platform

中图分类号:  R285.5